Advanced Proteome Therapeutics Corporation
APTCF · OTC
7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $5 | $3 | $3 | $4 |
| Gross Profit | -$5 | -$3 | -$3 | -$4 |
| % Margin | – | – | – | – |
| R&D Expenses | $687 | $391 | $412 | $621 |
| G&A Expenses | $272 | $122 | $567 | $920 |
| SG&A Expenses | $272 | $260 | $567 | $920 |
| Sales & Mktg Exp. | $0 | $138 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$409 | $0 |
| Operating Expenses | $960 | $651 | $570 | $939 |
| Operating Income | -$941 | -$651 | -$570 | -$926 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,538 | -$1,270 | $31 | $465 |
| Pre-Tax Income | $597 | -$1,920 | -$544 | -$465 |
| Tax Expense | $0 | $0 | -$61 | $0 |
| Net Income | $760 | -$1,835 | -$451 | -$333 |
| % Margin | – | – | – | – |
| EPS | 0.019 | -0.059 | -0.02 | -0.019 |
| % Growth | 132.7% | -190.6% | -5.2% | – |
| EPS Diluted | 0.019 | -0.059 | -0.02 | -0.019 |
| Weighted Avg Shares Out | 39,088 | 31,706 | 22,158 | 17,282 |
| Weighted Avg Shares Out Dil | 39,088 | 31,706 | 22,158 | 17,282 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $0 | $0 |
| Interest Expense | $29 | $27 | $30 | $23 |
| Depreciation & Amortization | $5 | $3 | $3 | $4 |
| EBITDA | -$937 | -$648 | -$567 | -$890 |
| % Margin | – | – | – | – |